9.21
price up icon1.87%   0.14
 
loading

Finanzdaten der Organon Co-Aktie (OGN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
5.35%
1,594.00
1,513.00 1,592.00 1,582.00 1,607.00
Cost Of Revenue
7.14%
720.00
672.00 696.00 659.00 668.00
Gross Profit
3.92%
874.00
841.00 896.00 923.00 939.00
Operating Expenses
12.84%
645.00
740.00 767.00 716.00 704.00
Interest Income/Expense
5.65%
131.00
124.00 132.00 126.00 131.00
Benefits Costs and Expenses
3.33%
1,365.00
1,412.00 1,463.00 1,375.00 1,372.00
Costs And Expenses
3.33%
1,365.00
1,412.00 1,463.00 1,375.00 1,372.00
Operating Income/Loss
126.73%
229.00
101.00 129.00 207.00 235.00
Income/Loss From Continuing Operations Before Tax
126.73%
229.00
101.00 129.00 207.00 235.00
Income Tax Expense/Benefit, Deferred
158.82%
10.00
-17.00 10.00 -196.00 21.00
Income Tax Expense/Benefit
500.00%
84.00
14.00 20.00 -152.00 40.00
Income/Loss From Continuing Operations After Tax
66.67%
145.00
87.00 109.00 359.00 195.00
Net Income/Loss
66.67%
145.00
87.00 109.00 359.00 195.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.81%
259.94
257.86 0.216 257.50 257.29
Diluted Average Shares
0.32%
260.16
261.00 0.244 259.76 258.60
Basic Earnings Per Share
64.71%
0.56
0.34 0.42 1.39 0.76
Diluted Earnings Per Share
69.70%
0.56
0.33 0.41 1.38 0.75
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
drug_manufacturers_general SNY
$50.23
price down icon 0.11%
$113.80
price down icon 0.82%
drug_manufacturers_general PFE
$25.09
price up icon 0.66%
$287.64
price down icon 0.53%
drug_manufacturers_general NVO
$56.34
price up icon 1.84%
drug_manufacturers_general MRK
$84.16
price down icon 0.96%
Kapitalisierung:     |  Volumen (24h):